Related Experiment Video
Updated: Aug 8, 2026
12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Acute myocardial infarction. Then and now
J Simmons1, H J Willens, K M Kessler
1Department of Medicine, University of Miami School of Medicine, Fla., USA.
Chest
|June 1, 1995
Summary
Management of acute myocardial infarction (AMI) has shifted from supportive care to restoring blood flow and preserving heart function. Modern strategies, including thrombolysis and percutaneous transluminal coronary angioplasty (PTCA), significantly reduce mortality.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Acute myocardial infarction (AMI) management has evolved significantly over the past decade.
- Historically, treatment focused on supportive measures for myocardial oxygen demand.
Observation:
- Current strategies emphasize restoring and maintaining infarct-related artery patency.
- Pharmacological (thrombolytic agents) and mechanical (percutaneous transluminal coronary angioplasty - PTCA) interventions are key to restoring blood flow.
- Early use of antiplatelet and anticoagulant agents prevents thromboembolic complications and maintains artery patency.
Findings:
- Beta-blockers and angiotensin-converting enzyme (ACE) inhibitors are crucial for myocardial conservation and preserving left ventricular function.
- Prophylactic antiarrhythmic drug use for arrhythmias is no longer routinely recommended.
- The therapeutic focus has shifted from solely reducing oxygen demand to improving oxygen delivery through interventions like PTCA and coronary artery bypass graft surgery.
Implications:
- These advancements have led to a significant reduction in myocardial infarction mortality.
- The integration of interventional procedures with advanced pharmacological therapies optimizes patient outcomes.
- Future research may further refine these strategies for enhanced cardiac recovery and reduced long-term complications.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...